Recent Insights Into Sleep Paralysis: Mechanisms and Management.
Vijay Bhalerao, Shashank Gotarkar, Deepak Vishwakarma, Sushim Kanchan
Cureus July 1, 2024 DOI: 10.7759/cureus.65413 (opens in new tab) via PubMed
Summary
AI-generated from the abstractSleep paralysis is a condition where people wake from deep sleep unable to move or speak, often with vivid hallucinations, caused by the persistence of REM sleep muscle atonia into wakefulness. Risk factors include sleep deprivation and irregular sleep patterns. Isolated episodes are generally benign, but recurrent episodes may need clinical attention, especially with distressing symptoms. The condition is prevalent across cultures and linked to various medical conditions but remains poorly understood. This review describes clinical characteristics, epidemiology, and risk factors, and discusses potential treatments including pharmacological interventions and cognitive-behavioral therapy, emphasizing the need for more research.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Hallucinations Risk factors Sleep paralysis Treatment modalities |
| Key finding | Sleep paralysis is associated with risk factors like sleep deprivation and irregular sleep patterns, and potential treatments include pharmacological interventions and cognitive-behavioral therapy. |
Abstract
Sleep paralysis (SP) is a phenomenon wherein individuals awaken from deep sleep but are unable to move or speak, often experiencing vivid hallucinations. This condition, attributed to the persistence of muscle atonia from rapid eye movement (REM) sleep into wakefulness, is associated with factors like sleep deprivation and irregular sleep patterns. While isolated episodes of SP are generally benign, recurrent episodes may warrant clinical attention, particularly when accompanied by distressing symptoms. Despite its prevalence across cultures and its documented association with various medical conditions, SP remains poorly understood by many. This review explores the clinical characteristics, epidemiology, and associated risk factors of SP, drawing from a comprehensive analysis of the existing literature. Additionally, the review discusses potential treatment modalities, including pharmacological interventions and cognitive-behavioral therapy, highlighting the need for further research to enhance our understanding and management of this intriguing phenomenon.